On August 20, 2026, China’s A-share market witnessed a collective upswing across its three major indices. The Shanghai Composite Index edged up by 0.24%, while the Shenzhen Component Index advanced 0.59%, and the ChiNext Index climbed 0.64%. In terms of sector performance, pharmaceutical stocks emerged as the standout performers, with broad-based gains across the board. Notably, CanSino, Changchun BCHT Biotechnology, and Walvax Biotechnology all hit their daily price limits, signaling robust investor enthusiasm. The precious metals sector also shone brightly, with Shandong Gold surging over 8% and Chifeng Gold rallying more than 7%, reflecting renewed optimism in the sector. Conversely, the semiconductor and robotics sectors faced significant headwinds. C U-Tree plummeted over 18%, Zhongda Leader slumped to its daily limit, Hygon Information declined more than 5%, and Cambricon shed over 3%, underscoring ongoing challenges in these technology-driven segments.